Thalidomide shows moderate inhibitory activity toward neuronal nitric oxide synthase (nNOS) and inducible NOS (iNOS), but not toward endothelial NOS (eNOS). Structural development studies of thalidomide yielded novel phenylhomophthalimide-type NOS inhibitors with enhanced activity and different subtype selectivity. (C) 2004 Elsevier Ltd. All rights reserved.
MODENA, T.;AZZOLINA, O.;GENTA, I.;MAZZA, M., FARMACO, 44,(1989) N-8, C. 721-729